Difference between revisions of "Category:Malignant solid neoplasm, ERBB2-mutated medications"
Jump to navigation
Jump to search
(Created page with "Medications with some degree of efficacy in the treatment of HER2+ tumors, regardless of anatomic site of origin. Category:Site-agnostic medications") |
m |
||
| Line 1: | Line 1: | ||
| − | Medications with some degree of efficacy in the treatment of HER2+ tumors, regardless of anatomic site of origin. | + | Medications with some degree of efficacy in the treatment of [[ERBB2 (HER2)|HER2+ tumors]], regardless of anatomic site of origin. |
[[Category:Site-agnostic medications]] | [[Category:Site-agnostic medications]] | ||
Revision as of 20:30, 26 April 2018
Medications with some degree of efficacy in the treatment of HER2+ tumors, regardless of anatomic site of origin.
Pages in category "Malignant solid neoplasm, ERBB2-mutated medications"
The following 5 pages are in this category, out of 5 total.